Search Results 1271-1280 of 17799 for monoclonal antibody

  1. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

    ... monoclonal antibody or hypersensitivity to pembrolizumab or any of its excipients. Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks ...

  2. Study Of TBio-6517, Given Intratumorally, Alone Or In Combination With Pembrolizumab, In Solid Tumors - Mayo Clinic

    ... monoclonal antibody (mAb) therapy within 45 days prior to study Day 1. Note: Patients are allowed to receive any of the following treatments up to 7 days ...

  3. Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis - Mayo Clinic

    ... monoclonal antibody * Participants with a history of autologous hematopoietic cell transplantation must have recovered from any transplant-related ...

  4. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    ... antibody (HCV ... History of anaphylaxis (excluding infusion related reactions) in association with previous anti-CD20 monoclonal antibody administration.

  5. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic expert answers questions about antibody testing for COVID-19 ... Science Saturday: Antibody testing, in pictures featured image. Research.

  6. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

    Subject who received any prior monoclonal antibodies against PD-1 or PD-L1 and/or any prior: Arm A only: ImiDs (eg, lenalidomide, thalidomide);; Arm B ...

  7. Transcriptomic Changes Before And After Anti-tnf Therapy Utilizing Optimum Therapeutic Drug Levels - Mayo Clinic

    About this study. The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus ...

  8. Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation

    Have a history of allergic reaction to prior monoclonal antibody or biologic agent Have received previous treatment with MORAb-004 (anti-TEM-1); Have a ...

  9. Medical Research & Education - Mayo Clinic News Network

    In a new study published in[...] Latest stories. Mayo Clinic expert answers questions about antibody testing ...

  10. Medical Research & Education - Mayo Clinic News Network

    Biotherapeutics. Training the workforce of the future in CAR T-cell therapy ; Mayo Clinic expert answers questions about antibody testing for COVID-19 featured ...